Insider Shareholders with Direct Ownership of Fate Therapeutics Inc (FATE)
This section provides a comprehensive overview of the insiders with direct ownership of Fate Therapeutics Inc (FATE). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
FATE THERAPEUTICS INC Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
J Scott Wolchko
President and CEO |
645,952 | 694,673 | 371,248 $464,060 | 50 |
Jan 09, 2024
Reduced 3.73%
|
Bahram Valamehr
President and CEO |
462,696 | 250,543 | 349,364 $436,705 | 27 |
Jan 10, 2025
Reduced 2.43%
|
717,807 | 480,618 | 336,707 $420,883 | 34 |
Jan 10, 2025
Reduced 1.65%
|
|
196,033 | 32,926 | 311,231 $389,038 | 8 |
Jan 19, 2023
Added 8.38%
|
|
0 | 5,980 | 270,203 $337,753 | 1 |
Jan 10, 2025
Reduced 2.17%
|
|
Yu Waye Chu
Chief Medical Officer |
101,760 | 29,159 | 140,676 $175,845 | 9 |
Apr 18, 2023
Reduced 1.62%
|
Mark Plavsic
Chief Technical Officer |
130,842 | 7,137 | 123,705 $154,631 | 5 |
Jan 10, 2023
Reduced 2.69%
|
Edward J Dulac Iii
Chief Financial Officer |
142,617 | 81,138 | 101,479 $126,848 | 18 |
Mar 04, 2024
Reduced 2.35%
|
Daniel D Shoemaker
Chief Scientific Officer |
14,411 | 59,482 | 73,020 $91,275 | 5 |
Mar 08, 2021
Reduced 1.08%
|
Brian T. Powl
Chief Commercial Officer |
45,000 | 3,854 | 41,146 $51,432 | 2 |
Jul 05, 2023
Reduced 8.56%
|
Michael Stewart Lee
Director |
11,331 | 0 | 11,331 $14,163 | 2 |
Jun 09, 2022
Added 43.29%
|
11,331 | 0 | 11,331 $14,163 | 2 |
Jun 09, 2022
Added 43.29%
|
|
11,331 | 0 | 11,331 $14,163 | 2 |
Jun 09, 2022
Added 43.29%
|
|
Robert Hershberg
Director |
11,331 | 672 | 10,659 $13,323 | 3 |
Jun 09, 2022
Added 44.8%
|
11,331 | 1,648 | 10,490 $13,112 | 4 |
Jun 09, 2022
Added 45.19%
|
|
11,331 | 1,439 | 9,892 $12,365 | 3 |
Jun 09, 2022
Added 46.65%
|
|
11,331 | 1,483 | 9,848 $12,310 | 3 |
Jun 09, 2022
Added 46.76%
|
|
13,394 | 4,725 | 8,669 $10,836 | 5 |
Aug 06, 2024
Reduced 6.8%
|